Related Experiment Video
Updated: Apr 25, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
[Diagnosis of thrombosis by hemostatic markers]
Abstract:
Hemostatic markers are measured when diagnosing cases presenting with either thrombosis or thrombophilia. Decreased antithrombin (AT), protein C and protein S levels, and positive anti-phospholipid antibody findings together suggest a risk for venous thromboembolism (VTE). Increased thrombin AT complex (TAT) and soluble fibrin (SF) levels indicate a hypercoagulable state, and the addition of elevated fibrinogen and fibrin degradation products (FDP) as well as D-dimer suggests the presence of VTE. D-dimer is frequently measured in VTE cases, but this marker is affected by fibrinolysis and requires standardization. The prothrombin time, FDP and fibrinogen are all used in the diagnosis of disseminated intravascular coagulation. Markedly reduced ADAMTS13 level is a useful sign for the diagnosis of thrombotic thrombocytopenic purpura.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

